Find Mepolizumab manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

17RELATED EXCIPIENT COMPANIES

38EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

API REF. PRICE (USD/KG)

$
$ 0
API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as:
Molecular Formula
C42H66O12
Molecular Weight
763.0  g/mol
InChI Key
PMOOKBAYUNEHOF-IKHMJLPLSA-N

Mepolizumab
1 2D Structure

Mepolizumab

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S,3S,4S,5R,6R)-6-[[(4aR,6aR,6bS,8aS,14aR,14bR)-8a-carboxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,13,14,14a-tetradecahydropicen-3-yl]oxy]-3,5-dihydroxy-4-[(1R,2R,3S,4R)-2,3,4-trihydroxycyclohexyl]oxyoxane-2-carboxylic acid
2.1.2 InChI
InChI=1S/C42H66O12/c1-37(2)16-18-42(36(50)51)19-17-40(6)21(22(42)20-37)8-11-26-39(5)14-13-27(38(3,4)25(39)12-15-41(26,40)7)53-35-31(47)32(30(46)33(54-35)34(48)49)52-24-10-9-23(43)28(44)29(24)45/h23-33,35,43-47H,8-20H2,1-7H3,(H,48,49)(H,50,51)/t23-,24-,25+,26-,27?,28+,29+,30+,31-,32+,33+,35-,39+,40-,41-,42+/m1/s1
2.1.3 InChI Key
PMOOKBAYUNEHOF-IKHMJLPLSA-N
2.1.4 Canonical SMILES
CC1(CCC2(CCC3(C(=C2C1)CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(C(O6)C(=O)O)O)OC7CCC(C(C7O)O)O)O)C)C)C)C(=O)O)C
2.1.5 Isomeric SMILES
C[C@]12CCC(C([C@@H]1CC[C@@]3([C@@H]2CCC4=C5CC(CC[C@@]5(CC[C@]43C)C(=O)O)(C)C)C)(C)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O[C@@H]7CC[C@H]([C@@H]([C@H]7O)O)O)O
2.2 Create Date
2012-02-15
3 Chemical and Physical Properties
Molecular Weight 763.0 g/mol
Molecular Formula C42H66O12
XLogP35.1
Hydrogen Bond Donor Count7
Hydrogen Bond Acceptor Count12
Rotatable Bond Count6
Exact Mass762.45542754 g/mol
Monoisotopic Mass762.45542754 g/mol
Topological Polar Surface Area203 Ų
Heavy Atom Count54
Formal Charge0
Complexity1530
Isotope Atom Count0
Defined Atom Stereocenter Count15
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content

Mepolizumab

About the Company : ​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological API...

​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry.
Shanghai Minbiotech CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMesochem is focused on incessant innovation along with the R&D of new APIs.

Flag China
Digital Content Digital Content

Mepolizumab

About the Company : Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine c...

Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine chemicals and fundamental chemical materials. It has an efficient research and development team. Beijing Mesochem provides its customers customized development, craft optimization, contract customization and outsourcing services. The company has a well-established industrial base in Weinan, Shanxi Province. The production base features a 20,000 ㎡ plant with a production capacity of over 8,000 MT per year.
Mesochem Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

GSK

United Kingdom
IOPC
Not Confirmed
arrow

GSK

United Kingdom
arrow
IOPC
Not Confirmed

MEPOLIZUMAB

Brand Name : NUCALA

Dosage Form : INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 125526

Regulatory Info :

Registration Country : USA

blank

02

GSK

United Kingdom
IOPC
Not Confirmed
arrow

GSK

United Kingdom
arrow
IOPC
Not Confirmed

Mepolizumabum

Brand Name : Nucala

Dosage Form : Inj L?s

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

GSK

United Kingdom
IOPC
Not Confirmed
arrow

GSK

United Kingdom
arrow
IOPC
Not Confirmed

Mepolizumabum

Brand Name : Nucala

Dosage Form : Inj L?s

Dosage Strength : 100mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

GSK

United Kingdom
IOPC
Not Confirmed
arrow

GSK

United Kingdom
arrow
IOPC
Not Confirmed

MEPOLIZUMAB

Brand Name : NUCALA

Dosage Form : SOLUTION

Dosage Strength : 100MG/ML

Packaging :

Approval Date :

Application Number : 2492989

Regulatory Info : Prescription

Registration Country : Canada

blank

05

GSK

United Kingdom
IOPC
Not Confirmed
arrow

GSK

United Kingdom
arrow
IOPC
Not Confirmed

MEPOLIZUMAB

Brand Name : NUCALA

Dosage Form : SOLUTION

Dosage Strength : 40MG/0.4ML

Packaging :

Approval Date :

Application Number : 2530821

Regulatory Info : Prescription

Registration Country : Canada

blank

06

GSK

United Kingdom
IOPC
Not Confirmed
arrow

GSK

United Kingdom
arrow
IOPC
Not Confirmed

Mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

07

GSK

United Kingdom
IOPC
Not Confirmed
arrow

GSK

United Kingdom
arrow
IOPC
Not Confirmed

Mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

08

GSK

United Kingdom
IOPC
Not Confirmed
arrow

GSK

United Kingdom
arrow
IOPC
Not Confirmed

Mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

09

GSK

United Kingdom
IOPC
Not Confirmed
arrow

GSK

United Kingdom
arrow
IOPC
Not Confirmed

Mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

GSK

United Kingdom
IOPC
Not Confirmed
arrow

GSK

United Kingdom
arrow
IOPC
Not Confirmed

Mepolizumab

Brand Name : Nucala

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Solubilizers

read-more
read-more

Parenteral

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Taste Masking

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Coating Systems & Additives

read-more
read-more

Co-Processed Excipients

read-more
read-more

Direct Compression

read-more
read-more

Rheology Modifiers

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for / Mepolizumab API manufacturers, exporters & distributors?

Mepolizumab manufacturers, exporters & distributors 1

98

PharmaCompass offers a list of Mepolizumab API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mepolizumab manufacturer or Mepolizumab supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mepolizumab manufacturer or Mepolizumab supplier.

PharmaCompass also assists you with knowing the Mepolizumab API Price utilized in the formulation of products. Mepolizumab API Price is not always fixed or binding as the Mepolizumab Price is obtained through a variety of data sources. The Mepolizumab Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Mepolizumab

Mepolizumab Manufacturers

A Mepolizumab manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mepolizumab, including repackagers and relabelers. The FDA regulates Mepolizumab manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mepolizumab API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Mepolizumab manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Mepolizumab Suppliers

A Mepolizumab supplier is an individual or a company that provides Mepolizumab active pharmaceutical ingredient (API) or Mepolizumab finished formulations upon request. The Mepolizumab suppliers may include Mepolizumab API manufacturers, exporters, distributors and traders.

click here to find a list of Mepolizumab suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Mepolizumab GMP

Mepolizumab Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Mepolizumab GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mepolizumab GMP manufacturer or Mepolizumab GMP API supplier for your needs.

Mepolizumab CoA

A Mepolizumab CoA (Certificate of Analysis) is a formal document that attests to Mepolizumab's compliance with Mepolizumab specifications and serves as a tool for batch-level quality control.

Mepolizumab CoA mostly includes findings from lab analyses of a specific batch. For each Mepolizumab CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Mepolizumab may be tested according to a variety of international standards, such as European Pharmacopoeia (Mepolizumab EP), Mepolizumab JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mepolizumab USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty